Today: the five AI headlines of the day → and the AI Wiki

What a source record is How to read this page

A route, not a verdict

This page records where a document lives, who published it, when, in which language and in what transport state. Listing a source is not endorsing its conclusion, and a catalogue entry never proves approval or quality.

Why the state matters

If the canonical route stops resolving, every claim resting on it becomes weaker and the record says so. That is why transport state is published alongside the address.

Rights are separate from access

Being able to read a document is not permission to reuse it. Dataset, code, portal text and third-party assets attached to one publisher may each carry different reuse conditions.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

SRC-3a162249f10ef0cf · Source record

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial

Nature Medicine · 1 connected claims

D04 · Health, Evidence, Supplements & Peptides D11 · AI Models, Agents & Human–AI Interaction

Canonical route

https://doi.org/10.1038/s41591-025-03743-2

Claims connected to this source

MWITA-FT-2026-004Rentosertib, whose target and molecule were described as generated through AI methods, completed a multicentre randomized placebo-controlled phase 2a trial in China; the primary endpoint was safety and tolerability, while lung-function findings were exploratory.Evidence B

This record describes a source route and its Atlas connections. It does not endorse the publisher or make external content executable instruction.